HEDS is part of the School of Health and Related Research (ScHARR) at the University of Sheffield. We undertake research, teaching, training and consultancy on all aspects of health related decision science, with a particular emphasis on health economics, HTA and evidence synthesis.

Wednesday, 29 January 2014

Cochrane Collaboration update

New and updated Cochrane Reviews highlighted on their website in January are:
  • Vitamin D supplementation for prevention of mortality in adults
  • Combination versus sequential single agent chemotherapy for metastatic breast cancer
  • Dihydroartemisinin-piperaquine for treating uncomplicated Plasmodium falciparum malaria
  • Aripiprazole versus other atypical antipsychotics for schizophrenia
  • Antidepressants for smoking cessation
  • Omalizumab for asthma in adults and children
  • Rehabilitation following surgery for lumbar spinal stenosis
  • Self-management education programmes for osteoarthritis
  • Antibiotics and antiseptics for venous leg ulcers
  • Duloxetine for treating painful neuropathy, chronic pain or fibromyalgia
  • Assisted reproductive technology: an overview of Cochrane Reviews
  • Treadmill training and body weight support for walking after stroke

There are also two new editorials giving contrasting views as to whether the Cochrane risk of bias tool should include funding source as a standard item.